Kestra Medical Technologies, Stock Fundamentals
| KMTS Stock | 27.52 0.03 0.11% |
Fundamental analysis of Kestra Medical allows traders to better anticipate movements in Kestra Medical's stock price by examining its financial health and performance throughout various phases of its business cycle.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Kestra Medical Technologies, Company Operating Margin Analysis
Kestra Medical's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Kestra Medical Operating Margin | (1.37) % |
Most of Kestra Medical's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Kestra Medical Technologies, is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Kestra Medical Technologies, has an Operating Margin of -1.3652%. This is 96.11% lower than that of the Health Care Equipment & Supplies sector and 70.89% lower than that of the Health Care industry. The operating margin for all United States stocks is 75.22% lower than that of the firm.
Kestra Medical Techn Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Kestra Medical's current stock value. Our valuation model uses many indicators to compare Kestra Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Kestra Medical competition to find correlations between indicators driving Kestra Medical's intrinsic value. More Info.Kestra Medical Technologies, is rated below average in profit margin category among its peers. It is rated below average in operating margin category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Kestra Medical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Kestra Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Kestra Medical's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Kestra Medical could also be used in its relative valuation, which is a method of valuing Kestra Medical by comparing valuation metrics of similar companies.Kestra Medical is currently under evaluation in operating margin category among its peers.
Kestra Fundamentals
| Profit Margin | (1.60) % | ||||
| Operating Margin | (1.37) % | ||||
| Current Valuation | 1.24 B | ||||
| Shares Outstanding | 51.35 M | ||||
| Shares Owned By Insiders | 6.09 % | ||||
| Shares Owned By Institutions | 87.32 % | ||||
| Number Of Shares Shorted | 1.95 M | ||||
| Price To Sales | 23.65 X | ||||
| Revenue | 59.81 M | ||||
| Gross Profit | 17.97 M | ||||
| EBITDA | (97.98 M) | ||||
| Net Income | (113.81 M) | ||||
| Total Debt | 44.31 M | ||||
| Book Value Per Share | (2,590) X | ||||
| Cash Flow From Operations | (77.61 M) | ||||
| Short Ratio | 5.03 X | ||||
| Earnings Per Share | (1.92) X | ||||
| Target Price | 27.5 | ||||
| Number Of Employees | 330 | ||||
| Market Capitalization | 1.24 B | ||||
| Total Asset | 295.74 M | ||||
| Retained Earnings | (520.25 M) | ||||
| Working Capital | 217.35 M | ||||
| Net Asset | 295.74 M |
About Kestra Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Kestra Medical Technologies,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kestra Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kestra Medical Technologies, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Kestra Stock Analysis
When running Kestra Medical's price analysis, check to measure Kestra Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kestra Medical is operating at the current time. Most of Kestra Medical's value examination focuses on studying past and present price action to predict the probability of Kestra Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kestra Medical's price. Additionally, you may evaluate how the addition of Kestra Medical to your portfolios can decrease your overall portfolio volatility.